Lobbying Filing Details

Activity 1

Financial Institutions/Investments/Securities

Coronavirus Aid, Relief, and Economic Security (CARES) Act
COVID-19 Legislation (Phase I, II, III and other)
Commercial paper market stability
COBRA Subsidies
Federal Medical Assistance Percentages (FMAP) increase
Special enrollment period
State and local funding support
COVID-19 testing, vaccinations, cost sharing for COVID-19 testing

Lobbyists (5)

• ELIZABETH HALL
• MR. SAMUEL JOHN MARCHIO
• ADAM GOLDBERG
• CATHERINE HANSEN NABAVI
• JAMES STURSBERG

Government Entities (4)

• SENATE
• HOUSE OF REPRESENTATIVES
• Health & Human Services, Dept of (HHS)
• Centers For Medicare and Medicaid Services (CMS)

Activity 2

Health Issues

ACA implementation (exchange operations and functionality, risk mitigation programs, risk adjustment)
ACA reform (reconciliation, individual mandate, cost sharing reduction subsidies, reinsurance transitional policies)
Individual market and exchange stabilization
Prior authorization and Utilization Management, (H.R. 3107); Uterine Fibroids Coverage
Hospital Consolidation
Privacy and Healthcare Cybersecurity
Digital, AI, and Blockchain
Social Determinants of Health (SDOH)
Mental health and substance use,42 CFR Part 2, Parity and compliance issues
Surprise medical billing; Lower Health Care Cost Act of 2019 (S. 1895), and No Surprises Act (H.R. 3630)
Price of prescription drugs
Commercial Risk adjustment data validation (RADV)
Senate HELP Committee Lower Health Care Costs Act
Senate Finance Committee Prescription Drug Pricing Reduction Act; (H.R. 3)
Pharmacy Benefit Manager (PBM) operations and practices, Spread pricing, Lower Health Care Cost Act of 2019 (S. 1895)
COVID-19 legislation (Phase I, II, III and other); Families First Coronavirus Response Act (H.R. 6201); Coronavirus Aid, Relief, and Economic Security (CARES) Act; The Heroes Act (H.R. 6800); HEALS Act (S. 1624); SEPs; Risk Mitigation and Excess Loss; COBRA; Testing and Coverage Mandates
Federal Medical Assistance Percentages (FMAP) increase

Lobbyists (5)

• ELIZABETH HALL
• MR. SAMUEL JOHN MARCHIO
• ADAM GOLDBERG
• CATHERINE HANSEN NABAVI
• JAMES STURSBERG

Government Entities (4)

• SENATE
• HOUSE OF REPRESENTATIVES
• Health & Human Services, Dept of (HHS)
• Centers For Medicare and Medicaid Services (CMS)

Activity 3

Insurance

ACA implementation (exchange operations and functionality, risk mitigation programs, risk adjustment)
ACA reform (reconciliation, individual mandate, cost sharing reduction subsidies, reinsurance transitional policies)
Individual market and exchange stabilization
Prior authorization and Utilization Management, (H.R. 3107); Uterine Fibroids Coverage
Hospital Consolidation
Privacy and Healthcare Cybersecurity
Digital, AI, and Blockchain
Social Determinants of Health (SDOH)
Mental health and substance use,42 CFR Part 2, Parity and compliance issues
Surprise medical billing; Lower Health Care Cost Act of 2019 (S. 1895), and No Surprises Act (H.R. 3630)
Price of prescription drugs
Commercial Risk adjustment data validation (RADV)
Senate HELP Committee Lower Health Care Costs Act
Senate Finance Committee Prescription Drug Pricing Reduction Act; (H.R. 3)
Pharmacy Benefit Manager (PBM) operations and practices, Spread pricing, Lower Health Care Cost Act of 2019 (S. 1895)
COVID-19 legislation (Phase I, II, III and other); Families First Coronavirus Response Act (H.R. 6201); Coronavirus Aid, Relief, and Economic Security (CARES) Act; The Heroes Act (H.R. 6800); HEALS Act (S. 1624); SEPs; Risk Mitigation and Excess Loss; COBRA; Testing and Coverage Mandates
Federal Medical Assistance Percentages (FMAP) increase

Lobbyists (5)

• ELIZABETH HALL
• MR. SAMUEL JOHN MARCHIO
• ADAM GOLDBERG
• CATHERINE HANSEN NABAVI
• JAMES STURSBERG

Government Entities (4)

• SENATE
• HOUSE OF REPRESENTATIVES
• Health & Human Services, Dept of (HHS)
• Centers For Medicare and Medicaid Services (CMS)

Activity 4

Medicare/Medicaid

Medicare Advantage (risk adjustment, coding intensity, encounter data, dual-eligible members, reauthorization of special need plans, star ratings, extreme and uncontrollable circumstances policy, normalization factors, stars contract
consolidation, ESRD, audio-only telehealth)
Medicare RAD-V
Mental health and substance use (42 CFR Part 2)
Medicaid managed care (MIND Act) (H.R. 6926) (IMD Exclusion)
Medicaid expansion
Medicaid reform (block grants, per capita caps)
Medicaid and CHIP reauthorization
Medicaid actuarial soundness
Long-term services and supports
Social Determents of Health (SDOH)
Medicare Part D prescription drug program and Medicare Part D coverage gap (donut hole)
Opioid addiction issues and response (prescription drug monitoring programs)
Medicaid medical loss ratio remittance
Medicare Advantage Pilot Program in TRICARE
Maternal Health Quality Improvement Act (H.R. 4995)
Pharmacy Benefit Manager (PBM) operations and practices, Spread pricing
Non Emergency Medical Transportation (The Protecting Patients Transportation to Care Act)(S.2846)
Medicaid maternal health coverage expansion (H.R.6800)

Lobbyists (5)

• ELIZABETH HALL
• MR. SAMUEL JOHN MARCHIO
• ADAM GOLDBERG
• CATHERINE HANSEN NABAVI
• JAMES STURSBERG

Government Entities (4)

• SENATE
• HOUSE OF REPRESENTATIVES
• Health & Human Services, Dept of (HHS)
• Centers For Medicare and Medicaid Services (CMS)